Revenue Integrity™
Growth That Holds.
Under Board Scrutiny. Under PE Pressure.
Revenue Integrity™
Growth That Holds.
Under Board Scrutiny. Under PE Pressure.
Revenue doesn't collapse. It leaks — slowly, quietly, and usually in the gap between what the commercial narrative promises and what product, GTM, and customer experience actually deliver.
By the time it shows in the numbers, the sequencing problem is harder to fix than the original issue.
Scaling doesn’t create the problem. It exposes it.
Growth stalls when revenue integrity breaks — not because of market conditions, but because trust, execution, or platform leverage can no longer keep up with the commercial narrative.
Healthcare technology ISVs experience this at every stage:
Early momentum hides fragility. Scale magnifies cracks. Diligence exposes what already exists.
Revenue integrity failure shows up as stalled expansion, inconsistent GTM execution, and fragile customer relationships — long before revenue declines. And it surfaces differently depending on where you are in the growth cycle.
Every company eventually hits one primary constraint. The stage doesn't determine the constraint — but it shapes where to look first.
Early Growth — Trust Constraint. Customers buy but don't expand. References hesitate. NDR underperforms.
Scale-Up — Execution Constraint. Pipeline grows but revenue lags. Sales cycles stretch unpredictably.
PE-Backed — Consistency Constraint. Growth exists but isn't durable. Board confidence in the narrative begins to erode.
Platform Roll-Up — Integration Constraint. Multiple products exist but don't deliver a coherent customer experience.
Pre-Exit — Durability Constraint. Revenue is real but valuation is being discounted against risks the business can't fully articulate.
Same operating system. Different pressure points.
We don't add growth. We identify the constraint limiting it — and define the path to resolve it.
All engagements are fixed-fee, time-boxed, and scoped to the specific inflection point. Work is senior-led throughout. Execution ownership stays with the client. No strategy decks without findings. No junior delivery.
IntegritySignals™ Fast signal clarity before a decision locks in — or before a board review, a PE diligence process, or a new commercial leader's assumptions harden into commitments.
Produces a Decision-Risk Heatmap, Signal Snapshot, and board-ready readout that separates what matters from what doesn't — with specific sequencing recommendations.
Typically completes in 30 days.
Revenue Integrity™ Assessment Enterprise-wide clarity across GTM, CX, product, and AI/cloud architecture. Produces a Revenue Integrity™ Score and a prioritized 30/60/90 roadmap that holds up under board and sponsor scrutiny.
The entry point for leadership teams that already know where the pressure is and need structured clarity on what to do about it.
Typically completes in 30 to 45 days.
Diagnostic Root cause identification when a specific constraint has already been named but the underlying cause hasn't been isolated. Heavy analysis, specific findings, actionable recommendations.
Typically completes in three to five weeks.
Strategic Retainer Ongoing decision presence through a PE value creation cycle or exit horizon. Monthly decision memos, recalibration guidance, and sequencing support as conditions change.
For leadership teams that need more than a one-time engagement — a sustained advisory relationship that stays current as the business evolves.
This is system-level clarity, not consulting theater.
ISV CEOs Remove the constraint limiting durable growth without guessing where to invest next. Get clarity on what actually matters — before the board meeting where the narrative has to hold.
PE Operating Partners Stabilize revenue durability before accelerating value creation. One engagement surfaces what diligence will find — before diligence finds it. PE-referred engagements are scoped for board and sponsor-level output from day one.
Boards Clarity on what actually limits scale, valuation, and defensibility. Board-defensible outputs in 30 to 45 days. Findings that hold up under the scrutiny of a diligence process or a value creation review.
Revenue Integrity™ wasn't built in a boardroom.
It was built across twenty years of operating on all three sides of the healthcare technology market — inside provider enterprises making technology decisions, inside a scaled health ISV where this approach produced the largest year-over-year KLAS improvement on record, and leading Healthcare & Life Sciences Technology Partnerships at AWS.
That combination — buyer, operator, and ecosystem — creates pattern recognition that's difficult to replicate from any single vantage point. Most advisory perspectives come from one side of the market. Very few have operated on all three before the market fully understood why that intersection mattered.
Strategic Tech Advisors works with a small number of CEOs, boards, and PE sponsors each year. Engagements are selective by design — because the work requires direct senior involvement at every stage.
When the cost of getting it wrong is material, we're always open to a quiet conversation.
The leaders who navigate growth inflection points well don't move faster.
They get clarity earlier — before assumptions harden into commitments and before the board meeting where the narrative has to hold.
Revenue Integrity™ will surface — either during growth or during diligence. The only variable is timing.
If you're a healthcare technology CEO, PE operating partner, or board member navigating one of these moments, reach out directly.
[Start the conversation → tim@strategictechadvisors.com]